Skip to main content
. 2019 Mar 18;9:4712. doi: 10.1038/s41598-019-41251-9

Table 1.

Tumor Growth Rate Constants in Animals treated with MN-siPDL1 or MN-siSCR and Gemcitabine.

Treatment Group Tumor growth rate constant (week−1)
High-dose MN-siPDL1 + gemcitabine (responder) 0.0813 ± 0.0502
High-dose MN-siPDL1 + gemcitabine (non-responder) 0.5427
Low-dose MN-siPDL1 + gemcitabine 0.3627 ± 0.0866
MN-siSCR + gemcitabine 0.5562 ± 0.24